Report interim data readout from Phase 3 PDS0301 trial in colorectal cancer with liver metastases
Deadline not yet reached (612 days left)
- Announced
- 21 Oct 2026
- Due
- 30 Jun 2028
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Q2-2028 Phase 3 – Colorectal cancer with liver metastases (Interim data readout)”
What we found
The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 30 Jun 2028.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout late
- Indicative materiality
- High rules
- Action
- Report
- Deliverable
- PDS0301 Phase 3 interim data readout in colorectal cancer with liver metastases
- In the company’s control
- Medium
- Specificity
- Medium
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you PDS Biotechnology Corp? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2026-PDSB-019869 · Corrections policy